• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人干扰素(HI)与分泌型免疫球蛋白(S-IgA)联合治疗人疱疹性角膜炎

Combined therapy of human interferon (HI) and secretory immunoglobulin (S-IgA) in the treatment of human herpetic keratitis.

作者信息

de la Pena N C, Diaz A, Damel A, Bal E, Puricelli L, Ejden J, de Lustig E S

出版信息

Biomedicine. 1978 May;28(2):104-8.

PMID:352419
Abstract

The topical action of a combined therapy of human interferon (3000 U/ml) and secretory immunoglobulin IgA (1,5 mg/ml) was studied in 56 patients with herpetic keratitis. The pain and photophobia disappeared within 48 h after the beginning of treatment and a marked reduction of the corneal lesion during the first week of treatment was observed in all the patients. The therapy was effective, with complete healing of the lesion in 94.8% of cases; 72.2% of them healed in less than 15 days. The highest frequency of healing was between 5 and 10 days, and the rest up to 30 days. Humoral, immunological and delayed hypersensitivity studies were carried out in 36 patients.

摘要

对56例疱疹性角膜炎患者研究了人干扰素(3000 U/ml)和分泌型免疫球蛋白IgA(1.5 mg/ml)联合治疗的局部作用。治疗开始后48小时内疼痛和畏光症状消失,所有患者在治疗第一周角膜病变均有明显减轻。该治疗有效,94.8%的病例病变完全愈合;其中72.2%在不到15天内愈合。愈合频率最高的是在5至10天之间,其余的在30天内愈合。对36例患者进行了体液、免疫和迟发型超敏反应研究。

相似文献

1
Combined therapy of human interferon (HI) and secretory immunoglobulin (S-IgA) in the treatment of human herpetic keratitis.人干扰素(HI)与分泌型免疫球蛋白(S-IgA)联合治疗人疱疹性角膜炎
Biomedicine. 1978 May;28(2):104-8.
2
[Combined therapy with secretory immunoglobulin A and human interferon in keratitis produced by Herpes simplex virus in the rabbit].[分泌型免疫球蛋白A与人干扰素联合治疗兔单纯疱疹病毒性角膜炎]
Medicina (B Aires). 1978 Jan-Feb;38(1):40-4.
3
[Clinical observation on the local treatment of viral keratoconjunctivitis using leukocytic interferon and immunoglobulins].[应用白细胞干扰素和免疫球蛋白局部治疗病毒性角膜结膜炎的临床观察]
Bull Mem Soc Fr Ophtalmol. 1982;94:133-6.
4
[Results of interferon therapy of patients with herpetic keratitis].[疱疹性角膜炎患者的干扰素治疗结果]
Vestn Oftalmol. 1968 Jan-Feb;81(1):72-4.
5
[Clinical trials of interferon in ophthalmology].[干扰素在眼科的临床试验]
Gan To Kagaku Ryoho. 1984 Feb;11(2):212-20.
6
[Importance of immunologic methods of diagnosis and substantiation of treatment of herpetic keratitis in children].[免疫诊断方法在儿童疱疹性角膜炎诊断及治疗依据中的重要性]
Oftalmol Zh. 1976;31(6):435-8.
7
Vidarabine therapy of simple and IDU-complicated herpetic keratitis.
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976 Sep-Oct;81(5):813-25.
8
E-rosette forming count determination and transfer factor treatment in herpetic simplex keratitis.
Chin Med J (Engl). 1983 Nov;96(11):860-4.
9
[Experimental study and clinical application of exogenous interferon against herpes simplex virus].外源性干扰素抗单纯疱疹病毒的实验研究与临床应用
Zhonghua Yan Ke Za Zhi. 1983 Nov;19(6):335-8.
10
[The use of an immunoglobulin in the comprehensive treatment of ophthalmic herpes].[免疫球蛋白在眼科疱疹综合治疗中的应用]
Oftalmol Zh. 1990(3):162-3.